Phantom pain and the risk of falling are the two major unsolved problems of leg and foot amputees. The Austrian company Saphenus Medical Technology is developing a sensory feedback system (IPS) that solves these two problems. The...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
SensAgain
Restoring of SENSAtions from Lost LeGs for health And qualIt...
100K€
Cerrado
SENSY
Restoring complete motor and sensory ability for natural wal...
71K€
Cerrado
MovEAID
A novel wearable medical device and eHealth system to improv...
71K€
Cerrado
GoSafe
Restoring complete sensory ability for natural walking of am...
4M€
Cerrado
RESHAPE
REstoring the Self with embodiable HAnd ProsthesEs
1M€
Cerrado
BFS
BIONIC FEEDBACK SYSTEM FOR AMPUTEES AND DIABETICS
3M€
Cerrado
Información proyecto IPS
Duración del proyecto: 6 meses
Fecha Inicio: 2018-07-09
Fecha Fin: 2019-01-31
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Phantom pain and the risk of falling are the two major unsolved problems of leg and foot amputees. The Austrian company Saphenus Medical Technology is developing a sensory feedback system (IPS) that solves these two problems. The novelty of IPS is the «feeling prosthesis» for the leg: The authentic capturing of the gait image represents a breakthrough innovation which does not exist in the global market so far. The key market application of IPS is cost-efficient, affordable, and an optimized care for amputees. The factor of pain in the form of phantom, neuroma or stump pain puts more than 50 percent of the amputees under pressure, and more than 2 million people throughout Europe are affected by a loss of their limbs. Saphenus brings to market a prosthesis solution that reduces or makes disappear phantom pains and brings cost savings of 50-85% to existing models. Social and health insurance institutions have recognized the socio-economic benefits of this breakthrough innovation of a direct cost saving of more than EUR 24,000 per year per pain-induced prosthesis wearers.